BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D'Adamo E, Castorani V, Nobili V. The Liver in Children With Metabolic Syndrome. Front Endocrinol (Lausanne) 2019;10:514. [PMID: 31428049 DOI: 10.3389/fendo.2019.00514] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu H, Sheen J, Hou C, Lin I, Huang L, Tain Y, Cheng H, Lai Y, Lin Y, Tiao M, Tsai C. Effects of Maternal Gut Microbiota-Targeted Therapy on the Programming of Nonalcoholic Fatty Liver Disease in Dams and Fetuses, Related to a Prenatal High-Fat Diet. Nutrients 2022;14:4004. [DOI: 10.3390/nu14194004] [Reference Citation Analysis]
2 Furthner D, Anderwald C, Bergsten P, Forslund A, Kullberg J, Ahlström H, Manell H, Ciba I, Mangge H, Maruszczak K, Koren P, Schütz S, Brunner SM, Schneider AM, Weghuber D, Mörwald K. Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease. Front Endocrinol 2022;13:830012. [DOI: 10.3389/fendo.2022.830012] [Reference Citation Analysis]
3 Avelar-rodríguez D, Peña-vélez R, Popov J, Hill L, Ryan PM. Probiotics and non-alcoholic fatty liver disease in children and adolescents: a systematic review. Rev Esp Enferm Dig 2022. [DOI: 10.17235/reed.2022.8796/2022] [Reference Citation Analysis]
4 Damar Ç, Işık E, Güngör Ş. Relationship between Quantitative Sonographic Measurements and Serum Biochemical Parameters in Childhood Obesity. Pediatr Gastroenterol Hepatol Nutr 2021;24:470-82. [PMID: 34557399 DOI: 10.5223/pghn.2021.24.5.470] [Reference Citation Analysis]
5 Brecelj J, Orel R. Non-Alcoholic Fatty Liver Disease in Children. Medicina (Kaunas) 2021;57:719. [PMID: 34357000 DOI: 10.3390/medicina57070719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Putri RR, Casswall T, Hagman E. Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity - a nationwide cross-sectional cohort study. BMC Pediatr 2021;21:271. [PMID: 34107897 DOI: 10.1186/s12887-021-02747-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bloyd M, Settas N, Faucz FR, Sinaii N, Bathon K, Iben J, Coon S, Caprio S, Stratakis CA, London E. The PRKAR1B p.R115K Variant is Associated with Lipoprotein Profile in African American Youth with Metabolic Challenges. J Endocr Soc 2021;5:bvab071. [PMID: 34195525 DOI: 10.1210/jendso/bvab071] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Flisiak-Jackiewicz M, Bobrus-Chociej A, Wasilewska N, Lebensztejn DM. From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-New Terminology in Pediatric Patients as a Step in Good Scientific Direction? J Clin Med 2021;10:924. [PMID: 33804296 DOI: 10.3390/jcm10050924] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
9 Suri A, Song E, van Nispen J, Voigt M, Armstrong A, Murali V, Jain A. Advances in the Epidemiology, Diagnosis, and Management of Pediatric Fatty Liver Disease. Clin Ther 2021;43:438-54. [PMID: 33597074 DOI: 10.1016/j.clinthera.2021.01.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
10 Sert A. Nonalcoholic fatty liver disease and cardiovascular risk in severely obese adolescents. Acta Diabetol 2021;58:121-2. [PMID: 32740703 DOI: 10.1007/s00592-020-01578-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dikaiakou E, Vlachopapadopoulou E, Fotiadou A, Athanasouli F, Kafetzi M, Fotinou A, Michalacos S. Association between obesity, dyslipidemia and insulin resistance with suspected fatty liver disease in Greek children with excess weight. AOWMC 2020;10:172-175. [DOI: 10.15406/aowmc.2020.10.00324] [Reference Citation Analysis]
12 Povarova OV, Gorodetskaya EA, Kalenikova EI, Medvedev OS. Metabolic markers and oxidative stress in children’s obesity pathogenesis. Ross vestn perinatol pediatr 2020;65:22-29. [DOI: 10.21508/1027-4065-2020-65-1-22-29] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Scudiero O, Pero R, Ranieri A, Terracciano D, Fimiani F, Cesaro A, Gentile L, Leggiero E, Laneri S, Moscarella E, Mazzaccara C, Frisso G, D'Alicandro G, Limongelli G, Pastore L, Calabrò P, Lombardo B. Childhood obesity: an overview of laboratory medicine, exercise and microbiome. Clin Chem Lab Med 2020;58:1385-406. [PMID: 31821163 DOI: 10.1515/cclm-2019-0789] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]